thiorphan has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krassói, I; Papp, JG; Pataricza, J | 1 |
1 other study(ies) available for thiorphan and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Thiorphan enhances bradykinin-induced vascular relaxation in hypoxic/hyperkalaemic porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Coronary Vessels; Drug Synergism; Hyperkalemia; Hypoxia; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Chloride; Protease Inhibitors; Swine; Thiorphan; Vasoconstrictor Agents; Vasodilator Agents | 2003 |